Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Looking At Johnson & Johnson's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Looking At Johnson & Johnson's Recent Whale Trades

Benzinga

COVID vaccines and pregnancy: a review of the evidence shows they are safe

COVID vaccines have been contentious ever since they were developed in response to the coronavirus pandemic, though the evidence is that they are safe and effective. One of the concerns has been whether the vaccines were safe for pregnant women. A recent review looked at the evidence available from North…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Check Out What Whales Are Doing With JNJ

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 15 strange trades.

Benzinga

How a Texas town is making itself into an epicenter of the US semiconductor universe

In downtown Sherman, Texas, markers explain the city’s past and restaurants and coffee shops boast about the historic buildings they call home.

Tribune News Service

Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years

Johnson & Johnson (NYSE:JNJ) has outperformed the market over the past 15 years by 1.01% on an annualized basis producing an average annual return of 7.22%. Currently, Johnson & Johnson has a market capitalization of $465.27 billion.

Benzinga

What Are Whales Doing With Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years

Johnson & Johnson (NYSE:JNJ) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 7.34%. Currently, Johnson & Johnson has a market capitalization of $469.49 billion.

Benzinga

Check Out What Whales Are Doing With JNJ

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades.

Benzinga

Looking At Johnson & Johnson's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

COVID-19 vaccines give 'huge boost' to researchers trying to save Tasmanian devils from facial tumour disease

Researchers trying to protect Tasmanian devils are given a "huge boost" in the battle against a deadly disease that has wreaked havoc in the wild, thanks to an unlikely source — the COVID-19 vaccine.

ABC News

What Are Whales Doing With Johnson & Johnson

Benzinga

J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement

Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).

Benzinga

Novavax's new shot may sway anti-vaxxers

Experts hope the new COVID vaccine, which uses older biotechnology, could help the unvaccinated come around

Salon

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With JNJ

Benzinga

Check Out What Whales Are Doing With JNJ

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

The New Daily

Planning a holiday? What’s the COVID situation in Bali, Fiji, NZ and the UK?

Here are a few general tips for a safer and enjoyable holiday, and a quick look at the COVID situation in four popular holiday destinations.

The Conversation

Planning a holiday? What's the COVID situation in Bali, Fiji, NZ and the UK?

Many of us are considering a long-delayed overseas trip. However, despite what our politicians are telling us, the pandemic is not over yet, and there is always the risk you could catch COVID on holiday or just before you depart.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Tentative $161.5 million settlement reached in opioid trial

Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement

Liverpool Echo

Cruise ship vaccination rules for UK passengers hitting the high seas

The rules differ for various liners as the industry looks to recover from the Covid-19 pandemic

Benzinga

What Are Whales Doing With Johnson & Johnson

Manchester Evening News

France holidays: Passport validity, Channel crossing, driving requirements and Covid and face mask rules explained

Holidaymakers need to have a Vaccination Certificate, or show proof of a negative Covid test, to be permitted to enter the country

The Hindu

A year on, Quad initiative for 1 billion India-made vaccines runs into rough weather

Production of Johnson & Johnson jab at Hyderabad-based firm’s facility stalled over indemnity and safety issues

WEKU

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

The Independent UK

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.